GILEAD SCIENCES's ticker is and the CUSIP is 375558954. A total of 1 filers reported holding GILEAD SCIENCES in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $140,326,000 | +20.5% | 1,198,547 | +1.0% | 0.03% | +22.2% |
| Q1 2015 | $116,425,000 | -54.9% | 1,186,437 | -56.6% | 0.03% | -54.2% |
| Q4 2014 | $257,933,000 | -10.5% | 2,736,400 | +1.1% | 0.06% | -13.2% |
| Q3 2014 | $288,133,000 | +103.6% | 2,706,750 | +58.6% | 0.07% | +88.9% |
| Q2 2014 | $141,494,000 | +17.0% | 1,706,600 | 0.0% | 0.04% | +9.1% |
| Q1 2014 | $120,930,000 | -82.1% | 1,706,600 | -81.1% | 0.03% | -82.8% |
| Q4 2013 | $676,696,000 | +19.4% | 9,010,600 | -0.0% | 0.19% | +14.3% |
| Q3 2013 | $566,546,000 | +20.9% | 9,011,400 | -1.4% | 0.17% | +12.8% |
| Q2 2013 | $468,479,000 | – | 9,137,500 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JPMORGAN CHASE & CO | 9,011,400 | $566,546,000 | 0.17% |